SpaceX unlocks 911M shares, expanding float to 12% amid valuation debate
SpaceX's free float expands to over 12% after unlocking 911 million shares, impacting ETF weightings. Former engineer Andre Lavoie plans to sell shares worth $23 million, while investor Gary Black criticizes valuation despite strong Q2 revenue of $7.8 billion and future Terafab investments.

*this image is generated using AI for illustrative purposes only.
Space Exploration Technologies Corp. unlocked approximately 911 million shares this week, expanding its free float from less than 5% to more than 12% and altering its weight in major passive investment funds. This significant increase in publicly tradable shares raises the company’s investable market capitalization in float-adjusted benchmarks like the Nasdaq-100, leading to a larger allocation for SpaceX within index-tracking ETFs. The shift amplifies exposure for investors in technology-focused funds, even without immediate new share purchases by these vehicles, while intensifying scrutiny over the company’s valuation following its public debut.
The initial lockup expiration is part of a staggered release schedule, with further expirations planned for Aug 20 and late September. Currently, 179 U.S.-listed ETFs hold SpaceX shares, with the Invesco QQQ Trust being the largest holder at nearly $6 billion. Other significant holders include the Invesco NASDAQ 100 ETF, Fidelity Nasdaq Composite Index ETF, Vanguard Growth ETF, and Vanguard Morningstar Mega Cap Growth ETF. As SpaceX’s float expands, these funds will see an increased concentration in the stock relative to other holdings.
Insider Activity and Market Reaction
The unlock has prompted immediate action from some early employees. Andre Lavoie, a former engineer who joined SpaceX in 2009 and left in 2015, stated he plans to sell more of his stake due to the stock’s volatility. Lavoie holds shares worth approximately $23 million from his original grant of 200,000 shares. "Every chance I get going forward, I’ll sell a little bit more," Lavoie said, noting he intends to use the proceeds to renovate a hotel. Conversely, investor Gary Black of The Future Fund LLC remains bearish, citing the stock’s drop from an all-time high of $225 per share to below its IPO price of $135 per share as evidence of overvaluation.
| Metric | Value |
|---|---|
| Shares Unlocked | 911 million |
| New Free Float | More than 12% |
| Previous Free Float | Less than 5% |
| Total Shares Outstanding | Approximately 13.09 billion |
| IPO Price | $135 per share |
Financial Context and Future Outlook
The lockup developments follow a strong second-quarter performance for SpaceX. The company reported revenue of $7.8 billion, nearly double the $4.1 billion generated in the prior-year quarter. This growth was driven primarily by Starlink, which added more than one million subscribers across 170 markets during the quarter. Despite reporting a net loss of $541 million compared to a prior-year loss of approximately $1 billion, SpaceX shares declined in after-hours trading, reflecting investor caution.
Looking ahead, CEO Elon Musk highlighted the launch of the first Starlink V3 satellites, noting they offer roughly ten times the capability of previous generations. Musk also touted the new Terafab semiconductor manufacturing facility in Grimes County, Texas, which will serve both the Optimus robot and SpaceX’s "AI spacecraft." The facility, costing up to $119 billion across all phases, targets 1 terawatt of annual AI compute capacity. Bullish investors like Gene Munster predict SpaceX could generate $135 billion in annual revenue for Calendar Year 2027, exceeding Street estimates of $100 billion.
What the Numbers Show
The divergence between operational growth and market sentiment is stark. While revenue nearly doubled year-over-year and net losses narrowed significantly, the stock price volatility suggests investors are pricing in high expectations for future capital deployment, particularly regarding the $119 billion Terafab project. The expansion of the free float to 12% provides liquidity but also introduces selling pressure from early insiders like Lavoie, contrasting with the bullish long-term thesis held by investors such as Peter Diamandis, who sees a potential $10 trillion valuation.
How will the staggered lockup expirations in August and September impact SpaceX's stock price stability and trading volume?
What are the potential risks to SpaceX's profitability if the $119 billion Terafab project faces cost overruns or technical delays?
Could the increased concentration of SpaceX in major ETFs like Invesco QQQ lead to heightened correlation with broader tech market volatility?

































